Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Inhibition of Aryl Hydrocarbon Receptor (AhR) Expression Disrupts Cell Proliferation and Alters Energy Metabolism and Fatty Acid Synthesis in Colon Cancer Cells

M. Karasová, J. Procházková, Z. Tylichová, R. Fedr, M. Ciganek, M. Machala, Z. Dvořák, B. Vyhlídalová, I. Zůvalová, J. Ehrmann, J. Bouchal, Z. Andrysík, J. Vondráček

. 2022 ; 14 (17) : . [pub] 20220831

Language English Country Switzerland

Document type Journal Article

Grant support
19-00236S Czech Science Foundation
NU21-03-00421 Ministry of Health
BBMRI-CZ No. CZ.02.1.01/0.0/0.0/16_013/0001674 European Regional Development Fund
RVO: 68081707 Czech Academy of Sciences
RO0520 Ministry of Agriculture
DRO-FNOL00098892 Ministry of Health

The aryl hydrocarbon receptor (AhR) plays a wide range of physiological roles in cellular processes such as proliferation, migration or control of immune responses. Several studies have also indicated that AhR might contribute to the regulation of energy balance or cellular metabolism. We observed that the AhR is upregulated in tumor epithelial cells derived from colon cancer patients. Using wild-type and the corresponding AhR knockout (AhR KO) variants of human colon cancer cell lines HCT116 and HT-29, we analyzed possible role(s) of the AhR in cell proliferation and metabolism, with a focus on regulation of the synthesis of fatty acids (FAs). We observed a decreased proliferation rate in the AhR KO cells, which was accompanied with altered cell cycle progression, as well as a decreased ATP production. We also found reduced mRNA levels of key enzymes of the FA biosynthetic pathway in AhR KO colon cancer cells, in particular of stearoyl-CoA desaturase 1 (SCD1). The loss of AhR was also associated with reduced expression and/or activity of components of the PI3K/Akt pathway, which controls lipid metabolism, and other lipogenic transcriptional regulators, such as sterol regulatory element binding transcription factor 1 (SREBP1). Together, our data indicate that disruption of AhR activity in colon tumor cells may, likely in a cell-specific manner, limit their proliferation, which could be linked with a suppressive effect on their endogenous FA metabolism. More attention should be paid to potential mechanistic links between overexpressed AhR and colon tumor cell metabolism.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22023400
003      
CZ-PrNML
005      
20221031095220.0
007      
ta
008      
221010s2022 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/cancers14174245 $2 doi
035    __
$a (PubMed)36077780
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Karasová, Martina $u Department of Cytokinetics, Institute of Biophysics of the Czech Academy of Sciences, 61265 Brno, Czech Republic $u Department of Experimental Biology, Faculty of Science, Masaryk University, 62500 Brno, Czech Republic
245    10
$a Inhibition of Aryl Hydrocarbon Receptor (AhR) Expression Disrupts Cell Proliferation and Alters Energy Metabolism and Fatty Acid Synthesis in Colon Cancer Cells / $c M. Karasová, J. Procházková, Z. Tylichová, R. Fedr, M. Ciganek, M. Machala, Z. Dvořák, B. Vyhlídalová, I. Zůvalová, J. Ehrmann, J. Bouchal, Z. Andrysík, J. Vondráček
520    9_
$a The aryl hydrocarbon receptor (AhR) plays a wide range of physiological roles in cellular processes such as proliferation, migration or control of immune responses. Several studies have also indicated that AhR might contribute to the regulation of energy balance or cellular metabolism. We observed that the AhR is upregulated in tumor epithelial cells derived from colon cancer patients. Using wild-type and the corresponding AhR knockout (AhR KO) variants of human colon cancer cell lines HCT116 and HT-29, we analyzed possible role(s) of the AhR in cell proliferation and metabolism, with a focus on regulation of the synthesis of fatty acids (FAs). We observed a decreased proliferation rate in the AhR KO cells, which was accompanied with altered cell cycle progression, as well as a decreased ATP production. We also found reduced mRNA levels of key enzymes of the FA biosynthetic pathway in AhR KO colon cancer cells, in particular of stearoyl-CoA desaturase 1 (SCD1). The loss of AhR was also associated with reduced expression and/or activity of components of the PI3K/Akt pathway, which controls lipid metabolism, and other lipogenic transcriptional regulators, such as sterol regulatory element binding transcription factor 1 (SREBP1). Together, our data indicate that disruption of AhR activity in colon tumor cells may, likely in a cell-specific manner, limit their proliferation, which could be linked with a suppressive effect on their endogenous FA metabolism. More attention should be paid to potential mechanistic links between overexpressed AhR and colon tumor cell metabolism.
655    _2
$a časopisecké články $7 D016428
700    1_
$a Procházková, Jiřina $u Department of Cytokinetics, Institute of Biophysics of the Czech Academy of Sciences, 61265 Brno, Czech Republic $1 0000000327388546
700    1_
$a Tylichová, Zuzana $u Department of Cytokinetics, Institute of Biophysics of the Czech Academy of Sciences, 61265 Brno, Czech Republic $1 0000000304335505
700    1_
$a Fedr, Radek $u Department of Cytokinetics, Institute of Biophysics of the Czech Academy of Sciences, 61265 Brno, Czech Republic $u International Clinical Research Center, St. Anne's University Hospital Brno, 65691 Brno, Czech Republic
700    1_
$a Ciganek, Miroslav $u Department of Pharmacology and Toxicology, Veterinary Research Institute, 62100 Brno, Czech Republic
700    1_
$a Machala, Miroslav $u Department of Pharmacology and Toxicology, Veterinary Research Institute, 62100 Brno, Czech Republic
700    1_
$a Dvořák, Zdeněk $u Department of Cell Biology and Genetics, Faculty of Science, Palacký University, 78371 Olomouc, Czech Republic $1 0000000239383585
700    1_
$a Vyhlídalová, Barbora $u Department of Cell Biology and Genetics, Faculty of Science, Palacký University, 78371 Olomouc, Czech Republic
700    1_
$a Zůvalová, Iveta $u Department of Cell Biology and Genetics, Faculty of Science, Palacký University, 78371 Olomouc, Czech Republic
700    1_
$a Ehrmann, Jiří $u Department of Clinical and Molecular Pathology, Institute of Molecular and Translational Medicine, Faculty of Medicine, Palacký University and University Hospital, 77900 Olomouc, Czech Republic
700    1_
$a Bouchal, Jan $u Department of Clinical and Molecular Pathology, Institute of Molecular and Translational Medicine, Faculty of Medicine, Palacký University and University Hospital, 77900 Olomouc, Czech Republic $1 0000000348421720
700    1_
$a Andrysík, Zdeněk $u Linda Crnic Institute for Down Syndrome, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA $u Department of Pharmacology, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA
700    1_
$a Vondráček, Jan $u Department of Cytokinetics, Institute of Biophysics of the Czech Academy of Sciences, 61265 Brno, Czech Republic $1 0000000340711969
773    0_
$w MED00173178 $t Cancers $x 2072-6694 $g Roč. 14, č. 17 (2022)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/36077780 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20221010 $b ABA008
991    __
$a 20221031095218 $b ABA008
999    __
$a ind $b bmc $g 1853849 $s 1174688
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2022 $b 14 $c 17 $e 20220831 $i 2072-6694 $m Cancers $n Cancers $x MED00173178
GRA    __
$a 19-00236S $p Czech Science Foundation
GRA    __
$a NU21-03-00421 $p Ministry of Health
GRA    __
$a BBMRI-CZ No. CZ.02.1.01/0.0/0.0/16_013/0001674 $p European Regional Development Fund
GRA    __
$a RVO: 68081707 $p Czech Academy of Sciences
GRA    __
$a RO0520 $p Ministry of Agriculture
GRA    __
$a DRO-FNOL00098892 $p Ministry of Health
LZP    __
$a Pubmed-20221010

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...